Kalohexis Appoints Tony Mitchell as Chief Financial Officer
NORTHBROOK, Ill., March 31, 2026 /PRNewswire/ -- Kalohexis, a clinical-stage biotechnology company harnessing the melanocortin system to shape the next era of metabolic disease care starting with obesity and cancer cachexia, today announced the appointment of Tony Mitchell as Chief...
CP
cision pr newswire
via Pr Newswire
Updated 2h ago

Source Verification
Corroboration Score: 1This story was independently reported by 1 sources. Click any source to read the original article.
Comments
0 commentsBe respectful and constructive.
Loading comments...
Previous
Trump Hits Out at France For Closing Airspace to US Military
Next

